MedTrace Logo

Rectal Misoprostol and Blood Loss During Abdominal Hysterectomy

NCT02265562 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 220

Last updated 2014-10-16

No results posted yet for this study

Summary

Hysterectomy, as any major operation, can cause complications, as hemorrhage which may occur in some cases and sometimes requiring blood transfusion. Recent study proved that misoprostol success in reducing blood loss during total abdominal hysterectomy when used once before the surgery.

Conditions

  • Blood Loss

Interventions

DRUG

Misoprostol

60 minutes before the surgery 400 μg of misoprostol (2 tablets of 200 μg) inserted rectally

DRUG

Placebo

60 minutes before the surgery 2 tablet of placebo inserted rectally

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Waleed El-khyatat, M.D. · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2015-05-31
Completion
2015-06-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02265562 on ClinicalTrials.gov